Founded in early 2016, the RUNX1 Research Program (RRP) is a research and advocacy venture committed to funding world-class, innovative and cross-disciplinary cancer research to find a cure for those individuals born with a RUNX1 mutation. They have made it their goal to support, inform, educate and connect patients and healthcare providers in the RUNX1 Community.
For more information, visit: https://www.runx1-fpd.org/.